Author: Atreya, Chintamani; Glynn, Simone; Busch, Michael; Kleinman, Steve; Snyder, Edward; Rutter, Sara; AuBuchon, James; Flegel, Willy; Reeve, David; Devine, Dana; Cohn, Claudia; Custer, Brian; Goodrich, Raymond; Benjamin, Richard J.; Razatos, Anna; Cancelas, Jose; Wagner, Stephen; Maclean, Michelle; Gelderman, Monique; Cap, Andrew; Ness, Paul
Title: Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026) Document date: 2019_5_29
ID: 0m2ganys_44
Snippet: We must remind ourselves that PI for cellular products is a major paradigm shift for transfusion safety. The systems currently available are the first generation and we will certainly see improvements over time that minimize the negative side of the balance sheet......
Document: We must remind ourselves that PI for cellular products is a major paradigm shift for transfusion safety. The systems currently available are the first generation and we will certainly see improvements over time that minimize the negative side of the balance sheet.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date